Not logged in Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor-Mutated Nonsquamous Non-Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study Aye, Phyu Sin; Barnes, Joanne; Laking, George; Cameron, Laird; Anderson, Malcolm; Luey, Brendan; Delany, Stephen; Harris, Dean; Mclaren, Blair; Brenman, Elliott; Wong, Jayden; Lawrenson, Ross; Arendse, Michael; Tin, Sandar Tin; Elwood, Mark; Hope, Philip; Mckeage, Mark James Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
Identification of MRP2 as a targetable factor limiting oxaliplatin accumulation and response in gastrointestinal cancer Myint, Khine; Biswas, Riya; Li, Yan; Jong, Nancy; Jamieson, Stephen; Liu, Johnson; Han, Catherine; Squire, Christopher; Merien, Fabrice; Lu, Jun; Nakanishi, Takeo; Tamai, Ikumi; McKeage, Mark Share Save
Share Save
Share Save
Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC McKeage, Mark J.; Kotasek, Dusan; Markman, Ben; Hidalgo, Manuel; Millward, Michael J.; Jameson, Michael B.; Harris, Dean L.; Stagg, Robert J.; Kapoun, Ann M.; Xu, Lu; Hughes, Brett G. M. Share Save
EGFR Mutation Testing of non-squamous NSCLC: Impact and Uptake during Implementation of Testing Guidelines in a Population-Based Registry Cohort from Northern New Zealand McKeage, Mark; Elwood, Mark; Tin, Sandar Tin; Khwaounjoo, Prashannata; Aye, Phyu; Li, Angie; Sheath, Karen; Shepherd, Phillip; Laking, George; Kingston, Nicola; Lewis, Christopher; Love, Donald Share Save
Share Save
Phase 2 study of ceritinib in ALKi-naive patients (pts) with ALK-rearranged (ALK plus ) non-small cell lung cancer (NSCLC): Whole body responses in the overall pt group and in pts with baseline brain metastases (BM) Felip, E.; Orlov, S.; Park, K.; Yu, C-J.; Tsai, C-M.; Nishio, M.; Dols, M. C.; McKeage, M.; Su, W-C.; Mok, T. S. K.; Scagliotti, G.; Spigel, D. R.; Passos, V. Q.; Chen, V.; Munarini, F.; Shaw, A. Share Save
Share Save
Share Save
A Phase Ib study of demcizumab (DEM, anti-DLL4) plus pemetrexed and carboplatin in patients with first line stage IIIb/IV non-squamous non-small cell lung cancer. McKeage, Mark; Kotasek, Dusan; Markman, Ben; Millward, Michael; Hildalgo, Manuel; Jameson, Michael; Harris, Dean; Stagg, Robert; Dupont, Jakob; Hughes, Brett Share Save
Share Save
Share Save
A Phase 1b Study of Demcizumab Plus Pemetrexed and Carboplatin in Patients with 1st Line Non-Small Cell Lung Cancer (NSCLC) McKeage, M.; Kotasek, D.; Millward, M.; Markman, B.; Jameson, M.; Hidalgo, M.; Harris, D.; Stagg, R.; Dupont, J.; Hughes, B. Share Save
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}